{
  "figure_1": "Patient selection from the database. BI basal insulin, HbA1c glycated hemoglobin, OAD oral antidiabetic, T2D type 2 diabetes",
  "figure_2": "Percentage of patients reaching their first HbA1c < 7% post-BI initiation. The numerator is defined as the number of patients who reached glycemic control (HbA1c < 7%) for the first time during each corresponding quarter; the denominator is defined as the number of patients who did not reach glycemic control prior to that quarter AND were still on BI treatment AND had at least one valid electronic medical records entry in that quarter. BI basal insulin, HbA1c glycated hemoglobin",
  "figure_3": "Kaplan–Meier curves for time to reach glycemic control (HbA1c < 7%) for the overall study cohort and the four subcohorts. BI basal insulin, HbA1c glycated hemoglobin, OAD oral antidiabetic"
}